Aveanna Healthcare Holdings (AVAH) risk factors, FY2024 10-K

Risks Related to Our Business and Industry

1. 01Competition among home health, hospice and durable medical equipment companies is intense
2. 02If we are unable to maintain relationships with existing patient referral sources, our business and consolidated financial condition, results of operations and cash flows could be materially adversely affected
3. 03The cost of healthcare is funded substantially by government and private insurance programs. If such funding is reduced or limited or no longer available, our business may be adversely impacted
4. 04Changes to Medicare and Medicaid rates or methods governing Medicare and Medicaid payments for our services could materially adversely affect our business
5. 05the reclassification of home health resource groups or long-term care diagnosis-related groups
6. 06The implementation of alternative payment models and the transition of Medicaid and Medicare beneficiaries to managed care organizations may limit our market share and could adversely affect our revenues
7. 07Because we are limited in our ability to control reimbursement rates received for our services, our business could be materially adversely affected if we are not able to maintain or reduce our costs to provide such services
8. 08The industry trend toward value-based purchasing may impact our financial results negatively
9. 09impact our ability to retain previously received payments or could subject us to future payment delays, which could have a material adverse effect on our business, financial position, results of operations and liquidity
10. 10Failure to maintain the security and functionality of our information systems, or to defend against or otherwise prevent a cybersecurity attack or breach, could adversely affect our business, financial position, results of operations and liquidity
11. 11The use of technology based on artificial intelligence presents risks relating to confidentiality, creation of inaccurate and flawed outputs and emerging regulatory risk, any or all of which may adversely affect our business and results of operations
12. 12Healthcare reform and other regulations could adversely affect our customers, which could have an adverse effect on their ability to make timely payments to us for our products and services
13. 13Changes in the case-mix of our patients, as well as payer mix and payment methodologies, may have a material adverse effect on our profitability
14. 14If we are unable to provide consistently high quality of care, our business and consolidated financial condition, results of operations, and cash flows will be adversely impacted
15. 15Quality reporting requirements may negatively impact Medicare reimbursement
16. 16Our hospice operations are subject to annual Medicare caps. If any of our hospice providers exceeds such caps, our business and consolidated financial condition, results of operations, and cash flows could be materially adversely affected
17. 17Our failure to negotiate favorable managed care contracts, or our loss of existing favorable managed care contracts, could have a material adverse effect on our business and consolidated financial condition, results of operations and cash flows
18. 18Our business, financial condition and results of operations may be materially adversely affected by national public health emergencies, such as a pandemic or other infectious disease outbreak
19. 19The home health and hospice industries have historically experienced shortages in qualified employees and management, and competition for qualified personnel may increase our labor costs and reduce profitability
20. 20Any economic downturn, deepening of an economic downturn or federal and state budget pressures may result in a reduction in payments and covered services
21. 21Our business is dependent on the availability, integrity and security of internal and external information systems and IT services, but there are risks of business disruption associated with new business systems and technology initiatives
22. 22We develop and maintain portions of our clinical software systems in house. Failure of, or problems with, our systems could harm our business and operating results
23. 23If any of our home health or hospice agencies fail to comply with the conditions of participation in the Medicare program, that agency could be terminated from Medicare, which could adversely affect our revenue and net income
24. 24We may not be able to adequately obtain and maintain our intellectual property and proprietary rights, which could impair our ability to protect and enforce intellectual property and our brand
25. 25We may become subject to intellectual property disputes, which could be costly and may subject us to significant liability and increased costs of doing business
26. 26We have substantial indebtedness, which will increase our vulnerability to general adverse economic and industry conditions and may limit our ability to pursue strategic alternatives and react to changes in our business and industry or pay dividends
27. 27If we are unable to extend the maturity date of our debt facilities as needed on a long-term basis, this could have a material adverse effect on our business
28. 28Our variable rate indebtedness subjects us to interest rate risk, which could cause our indebtedness service obligations to increase significantly
29. 29We may not be able to identify, acquire, successfully integrate and obtain financing for strategic and accretive acquisitions
30. 30Federal regulation may impair our ability to consummate acquisitions or open new branch locations
31. 31We are a party to lawsuits, claims and governmental inquiries in the normal course of our business. See Note 13 – Commitments and Contingencies to the audited consolidated financial statements included in Part II, Item 8, of this Annual Report on Form 10-K (the "Consolidated Financial Statements")
32. 32our business, results of operations or financial condition, and we could incur substantial monetary liability and/or be required to change our business practices
33. 33Moreover, we could also be subject to potential litigation associated with compliance with various laws and governmental regulations at the federal or state levels, such as those relating to the protection of persons with disabilities, employment, health, safety, security and other regulations under which we operate
34. 34Our balance sheet includes a significant amount of goodwill and intangible assets. An impairment in the carrying value of goodwill could negatively impact our consolidated results of operations and total assets
35. 35If we are unable to maintain our corporate reputation, or there is adverse publicity or changes in public perception of our services, our business may suffer
36. 36We are sensitive to regional weather conditions that may adversely affect our operations
37. 37We may be more vulnerable to the effects of a public health catastrophe than other businesses due to the nature of our patients, and a regional or global socio-political or other catastrophic event could severely disrupt our business
38. 38We depend on the services of our executive officers and other key employees
39. 39Our ability to use our net operating losses to offset future taxable income may be subject to certain limitations
40. 40Unanticipated changes in tax law or adverse outcomes resulting from examination of our income or other tax returns could adversely affect our consolidated results of operations, financial condition, and cash flows
41. 41lower than anticipated future earnings in jurisdictions where we have lower statutory tax rates and higher than anticipated future earnings in jurisdictions where we have higher statutory tax rates

Risks Related to Our Regulatory Framework

1. 42Healthcare reform has initiated significant changes to the U.S. healthcare system
2. 43We conduct business in a heavily regulated industry, and changes in regulations, the enforcement of these regulations, or violations of regulations may result in increased costs or sanctions that reduce our revenues and profitability
3. 44Many states have CON laws or other regulatory provisions that may adversely impact our ability to expand into new markets and thereby limit our ability to grow and increase revenue
4. 45We face and are currently subject to reviews, audits and investigations under our contracts with federal and state government agencies and other payers, and these reviews, audits and investigations could have adverse findings that may negatively impact our business
5. 46We are subject to extensive and complex federal and state government laws and regulations that govern and restrict our relationships with physicians and other referral sources
6. 47Additionally, if we violate the Anti-Kickback Statute or the Stark Law, or if we improperly bill for our services, we may be found to violate the FCA, either under a suit brought by the government or by a private person under a qui tam, or “whistleblower,” lawsuit

Risks Related to Ownership of Our Common Stock

1. 48You may be diluted by future issuances of additional shares of common stock in connection with our incentive plans, acquisitions or otherwise; future sales of such shares in the public market, or the expectations that such sales may occur, could lower our stock price
2. 49We may issue preferred stock whose terms could adversely affect the voting power or value of our common stock
3. 50We do not intend to pay dividends for the foreseeable future
4. 51We take advantage of certain “controlled company” exemptions to the corporate governance rules for publicly listed companies, which could make our common stock less attractive to some investors or otherwise harm our stock price
5. 52Our Sponsors can significantly influence our business and affairs and may have conflicts of interest with us in the future
6. 53We face increased insurance, legal, accounting, and other corporate related costs and expenses as a public company. For example, our director and officer liability insurance policy costs increased significantly upon becoming a public company
7. 54Anti-takeover provisions in our governing documents and under Delaware law could make an acquisition of our company more difficult, limit attempts by our stockholders to replace or remove our current management and limit the market price of our common stock
8. 55advance notice procedures, which apply for stockholders to nominate candidates for election as directors or to bring matters before an annual meeting of stockholders
9. 56Our Amended Charter designates specific courts as the exclusive forum for certain litigation that may be initiated by our stockholders, which could limit our stockholders’ abilities to obtain a favorable judicial forum for disputes with us or our directors, officers or employees
10. 57Our Amended Charter provides that the doctrine of “corporate opportunity” does not apply with respect to any officer, director or stockholder who is not employed by us or our subsidiaries
11. 58If securities analysts do not publish research or reports about our company, or if they issue unfavorable commentary about us or our industry or downgrade our common stock, the price of our common stock could decline
12. 59If our operating and financial performance in any given period does not meet or exceed the guidance that we provide to the public, the market price of our common stock may decline